Literature DB >> 21727647

Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan.

Muhammad Sohail Afzal1, Sadia Tahir, Amna Salman, Tahir Ahmed Baig, Talha Shafi, Najm Us Sahar Sadaf Zaidi, Ishtiaq Qadri.   

Abstract

INTRODUCTION: Hepatitis C virus (HCV) commonly causes a chronic infection but few of patients are able to clear the virus naturally. Interleukin-10 (IL-10) is an anti-inflammatory cytokine that can suppress the immune response against HCV. Interindividual variations in IL-10 production are genetically contributed by polymorphisms within the IL-10 promoter region. This study aimed to investigate the association of the IL-10 gene promoter -1082 G/A, -819 C/T, and -592 C/A polymorphisms with HCV infection susceptibility in Pakistani individuals.
METHODOLOGY: Eighty-nine chronically infected patients and 99 controls were enrolled in the study. IL-10 (-1,082 G/A, -819 C/T, -592 C/A) genotyping was performed by amplification refractory mutation system-polymerase chain reaction (ARMS-PCR).
RESULTS: A suggestive evidence of association with hepatitis C was obtained for the IL-10 -819 C/T (-592 C/A) (p: 0.03) promoter polymorphism at the allele level  but not in genotype distribution. The IL-10 -1082 allele showed no association while positive association of GG (p: 0.001) gene and negative association for GA (0.001) gene were observed.  Higher frequencies were observed for GTA (p: 0.02), ACC (p: 0.01) haplotype and GCC/GTA (p: 0.005) diplotype in HCV patients than controls while diplotype GCC/ATA showed protective effect against HCV.
CONCLUSIONS: Our findings suggest that different IL-10 gene polymorphisms may lead to an imbalance between the pro-inflammatory and anti-inflammatory cytokine responses which may in turn influence the susceptibility to HCV infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21727647     DOI: 10.3855/jidc.1338

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  15 in total

1.  Is the IL-10 -819 polymorphism associated with visceral leishmaniasis?

Authors:  Mehrdad Hajilooi; Kosro Sardarian; Maryam Dadmanesh; Mohamad Matini; Pegah Lotfi; Ahad Bazmani; Mohammad Amin Tabatabaiefar; Mohammad Kazemi Arababadi; Mohammad Momeni
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

2.  Diagnostically untypable hepatitis C virus variants: it is time to resolve the problem.

Authors:  Muhammad Sohail Afzal; Muhammad Yousaf Khan; Muhammad Ammar; Sadia Anjum; Najm Us Sahar Sadaf Zaidi
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

3.  Malassezia Yeast and Cytokine Gene Polymorphism in Atopic Dermatitis.

Authors:  Charu Jain; Shukla Das; V G Ramachandran; Rumpa Saha; S N Bhattacharya; Sajad Dar
Journal:  J Clin Diagn Res       Date:  2017-03-01

4.  Three polymorphisms in the IL-10 gene and the risk of HCV infection: a meta-analysis plus a Chinese Association Study involving 1140 subjects.

Authors:  J Li; Y Liu; F Xu; J Chen; Y Chen
Journal:  Epidemiol Infect       Date:  2012-09-27       Impact factor: 4.434

5.  IL28B and IL10R -1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort.

Authors:  Alajos Pár; Gabriella Pár; István Tornai; Ferenc Szalay; Dalma Várszegi; Edit Fráter; Mária Papp; Gabriella Lengyel; János Fehér; Márta Varga; Judit Gervain; János Schuller; Zsuzsanna Nemes; Zoltán Péterfi; Anna Tusnádi; Béla Hunyady; Attila Haragh; Zsolt Szinku; Aron Vincze; László Szereday; Péter Kisfali; Béla Melegh
Journal:  BMC Res Notes       Date:  2014-01-08

6.  Hepatitis C virus capsid protein and intracellular lipids interplay and its association with hepatic steatosis.

Authors:  Muhammad Sohail Afzal; Najam Us Sahar Sadaf Zaidi; Jean Dubuisson; Yves Rouille
Journal:  Hepat Mon       Date:  2014-08-11       Impact factor: 0.660

7.  Association of interleukin-10 polymorphisms with chronic hepatitis C virus infection in a case-control study and its effect on the response to combined pegylated interferon/ribavirin therapy.

Authors:  A J Khan; V A Saraswat; G Choudhuri; D Parmar; T S Negi; S Mohindra
Journal:  Epidemiol Infect       Date:  2014-03-18       Impact factor: 4.434

8.  Effect of Functional Interleukin-10 Polymorphism on Pegylated Interferon-α Plus Ribavirin Therapy Response in Chronic Hepatitis C Virus Patients Infected With 3a Genotype in Pakistani Population.

Authors:  Muhammad Sohail Afzal; Sadia Anjum; Najam Us Sahar Sadaf Zaidi
Journal:  Hepat Mon       Date:  2013-06-08       Impact factor: 0.660

9.  Comparison of HCV prevalence in pakistan and iran; an insight into future.

Authors:  Muhammad Sohail Afzal; Tahir Ahmed; Najam Us Sahar Sadaf Zaidi
Journal:  Hepat Mon       Date:  2014-01-12       Impact factor: 0.660

10.  Association Between IL-10 Gene Promoter Polymorphisms (-592 A/C, -819 T/C, -1082 A/G) and Susceptibility to HBV Infection in an Iranian Population.

Authors:  Bita Moudi; Zahra Heidari; Hamidreza Mahmoudzadeh-Sagheb; Mohammad Hashemi; Malihe Metanat; Soheila Khosravi; Parisa Farrokh
Journal:  Hepat Mon       Date:  2016-02-20       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.